Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF)
OTCMKTS · Delayed Price · Currency is USD
2.300
-0.370 (-13.86%)
At close: Aug 4, 2025
SFOSF Market Cap
SFOSF has a market cap or net worth of $11.28 billion as of September 9, 2025. Its market cap has increased by 40.98% in one year.
Market Cap
11.28B
Enterprise Value
16.06B
Revenue
5.60B
Ranking
n/a
PE Ratio
24.90
Stock Price
$2.30
Market Cap Chart
Since August 9, 2005, SFOSF's market cap has increased from 539.79M to 11.28B, an increase of 1,990.58%. That is a compound annual growth rate of 16.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 11.28B | 37.78% |
| Dec 31, 2024 | 8.19B | -5.76% |
| Dec 29, 2023 | 8.69B | -31.08% |
| Dec 30, 2022 | 12.60B | -29.69% |
| Dec 31, 2021 | 17.92B | -6.98% |
| Dec 31, 2020 | 19.27B | 106.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 825.37M |
| Elite Pharmaceuticals | 749.52M |
| Tian'an Technology Group | 705.53M |
| Glass House Brands | 600.00M |
| HealthLynked | 499.79M |
| CytoDyn | 396.74M |
| Northwest Biotherapeutics | 376.41M |